University of Arkansas for Medical Sciences Myeloma Center

University of Arkansas for Medical Sciences Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease, Amyloidosis, and Waldenstrom Macroglobulemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates.

The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments. The quality of their innovative clinical and basic science research is highly regarded throughout the world.

The Myeloma Center routinely uses advanced diagnostics, such as Gene Array Analysis and DNA Sequencing, for determining optimal care management and planning therapy. Advanced diagnostics enable us to identify the specifics of each patient’s disease and personalize a course of treatment for the best possible results.

The team includes healthcare professionals in the following areas:

Hematology and Oncology:

Frits van Rhee, MD, PhD; Maurizio Zangari, MD